Despite this, mutations in CDC42-related genes are very low at between 0.1 and 1.7% and the elevated CDC42 expression in breast cancer is thought to be due to activation of oncogenes or cell surface receptors (for example; epidermal growth factor receptor (EGFR)) that lead to CDC42 upregulation46. The gene discussed is CD177; the disease is breast cancer.